Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma
  1. Home
  2. Publications
  3. Supplementary Table S1 from A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma

Supplementary Table S1 from A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma

Authors:
  • HLHyun-Sung Lee
    Hyun-Sung Lee
  • HJHee-Jin Jang
    Hee-Jin Jang
  • MRMaheshwari Ramineni
    Maheshwari Ramineni
  • DWDaniel Y. Wang
    Daniel Y. Wang
  • DRDaniela Ramos
    Daniela Ramos
  • JCJong Min Choi
    Jong Min Choi
  • TSTaylor Splawn
    Taylor Splawn
  • MEMonica Espinoza
    Monica Espinoza
  • MAMichelle Almarez
    Michelle Almarez
  • LHLeandria Hosey
    Leandria Hosey
  • EJEunji Jo
    Eunji Jo
  • SHSusan Hilsenbeck
    Susan Hilsenbeck

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30707251
Abstract
Supplementary Table 1. Representativeness of Study Participants
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • IMMUNOLOGY
  • SYSTEMS IMMUNOLOGY
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • COMBINATION IMMUNOTHERAPY
  • RARE CANCERS
  • TUMOR MICROENVIRONMENT
  • IMMUNE CELLS AND THE MICROENVIRONMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.